for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

HABA LABORATORIES, INC.

4925.T

Latest Trade

7,280.00JPY

Change

-60.00(-0.82%)

Volume

5,100

Today's Range

7,260.00

 - 

7,340.00

52 Week Range

6,200.00

 - 

9,390.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
7,340.00
Open
7,340.00
Volume
5,100
3M AVG Volume
0.12
Today's High
7,340.00
Today's Low
7,260.00
52 Week High
9,390.00
52 Week Low
6,200.00
Shares Out (MIL)
3.93
Market Cap (MIL)
28,646.80
Forward P/E
--
Dividend (Yield %)
0.55

Next Event

Q3 2020 Haba Laboratories Inc Earnings Release

Latest Developments

More

Haba Laboratories names Noriko Koyanagi as president

Haba Laboratories to merge wholly owned cosmetics unit

HABA LABORATORIES to issue year-end dividend for FY 2015

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About HABA LABORATORIES, INC.

HABA LABORATORIES, INC. is principally engaged in the manufacture and sale of cosmetics and dietary supplements. The Company's main business consists of the research, development, manufacture and distribution of women's and men's cosmetics. The Company offers its products by wholesale distribution to department stores and through mail order services to general customers. It also handles wholesale distribution to retailers and wholesalers, as well as the sale of products at its own retail stores.

Industry

Personal & Household Prods.

Contact Info

1-24-11, Kanda Suda-cho

+81.3.52966250

http://www.haba.com/

Executive Leadership

Masayuki Koyanagi

Chairman of the Board, Chairman of Subsidiary, Representative Director

Noriko Koyanagi

President, Representative Director

Noriyasu Komata

Director in charge of Finance & Accounting, General Affairs & Human Resources, Operation, Information Development, International Unit, Chairman of Subsidiary, Director

Kazuyuki Umezu

President of Subsidiary, Director

Akio Fujii

Managing Director

Key Stats

Price To Earnings (TTM)
12.04
Price To Sales (TTM)
1.44
Price To Book (MRQ)
2.25
Price To Cash Flow (TTM)
9.57
Total Debt To Equity (MRQ)
21.68
LT Debt To Equity (MRQ)
11.30
Return on Investment (TTM)
18.61
Return on Equity (TTM)
14.29

Latest News

Latest News

BRIEF-Haba Laboratories names Noriko Koyanagi as president

Haba Laboratories Inc : * Says it names Noriko Koyanagi as president * Says effective April 1 Source text in Japanese:https://goo.gl/hqhhVs Further company coverage: (Beijing Headline News)

BRIEF-Haba Laboratories to merge wholly owned cosmetics unit

* Says the co plans to merge its wholly owned unit, a Tokyo-based cosmetics firm

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up